Professor Karina Butler:

Those numbers are available and the HSE would have them. I do not have them to hand today. I do not remember and I would not want to give the Deputy misinformation.

The Deputy's first question is very important. In fact, that was the first category of people for whom we recommended boosters. Those with immunocompromising conditions or who are undergoing treatments that compromise that ability to respond to their primary course will get booster doses. That would include, for example, patients with haematological malignancies who are in that recent phase. That is outlined and will be done in parallel with the groups that we prioritised in the beginning for vaccination. That is already in place.